Michael John Sumner
Chief Medical Officer · INOVIO PHARMACEUTICALS, INC.
Individual
- 2024
- May 21, 2026
- 9
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Michael John Sumner's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael John Sumner?
Michael John Sumner is a corporate insider, tracked as Chief Medical Officer of INOVIO PHARMACEUTICALS, INC. (INO). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Michael John Sumner last file a Form 4?
The most recent primary Form 4 on record is dated 21 May 2026, one of 9 filings going back to 2024.
